Trials / Active Not Recruiting
Active Not RecruitingNCT05953064
Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects
Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects (FEAST): a Randomised, Double-blind, Placebocontrolled, Crossover Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
This study is an investigator-initiated, randomised, double-blind, placebo-controlled, cross-over human trial investigating the effect of DHA-NAT (C22:6 N-acyl taurine, an endogenous metabolite derived from the omega-3 fatty acid, docosahexaenoic acid) on postprandial plasma triglyceride levels following a high-fat meal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | DHA-NAT | Endogenous metabolite of omega-3 fatty acid docosahexaenoic acid |
| OTHER | Placebo | Vehicle control (H2O) for the intervention used in the experimental arm (DHA-NAT). |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-10-31
- Completion
- 2025-04-01
- First posted
- 2023-07-19
- Last updated
- 2025-03-30
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05953064. Inclusion in this directory is not an endorsement.